Texas judge’s ruling to halt mifepristone approval was contradicted by a second ruling, throwing the drug’s future into doubt
Poppy Noor
Sat 8 Apr 2023
A federal judge in Texas on Friday suspended the Food and Drug Administration’s approval of mifepristone, one of the two drugs commonly used to end a pregnancy, throwing the future of the drug into question.
District court judge Matthew Kacsmaryk stayed his order, a preliminary injunction, for seven days to give the FDA time to appeal. Less than an hour after the Friday ruling, another federal judge in a separate case in Washington state directly contradicted Kacsmaryk’s ruling, ordering the FDA to refrain from making any changes to the availability of mifepristone.
Continued: https://www.theguardian.com/us-news/2023/apr/07/abortion-pill-ruling-explainer-mifepristone